Breast Service Line*​​

Neuro

PATHOLOGY​

Breast Cancer​

VENDOR​

Transpara

APP Transpara​

DESCRIPTION​

Transpara enables the concurrent reading of mammograms and digital breast tomosynthesis (DBT) examinations. The system can identify high-risk breast lesions, and AI markers highlight suspicious calcifications and soft tissue lesions together with an objective Region Score.​​1

MODALITY​​
X-Ray (2D & 3D)​


510(k) cleared​

PATHOLOGY​

Breast Density​

VENDOR

ClariSIGMAM

APP ClariSIGMAM​

DESCRIPTION​

ClariSIGMAM automatically analyzes 2D digital mammograms to assess breast tissue composition. The software assesses the breast density of women and generates a breast density group information for the patient in accordance with the American College of Radiology’s Breast Imaging Reporting and Data System (BI-RADS) density classification scale.​2

MODALITY​​
X-Ray (2D)​


510(k) cleared​​

*Currently not available within the Calantic Viewer. Separately distributed by Bayer.​​

  1. Instructions for Use Transpara, software version 1.7.1
  2. Instructions for Use ClariSIGMAM, software version 1.1​​
LinkedIn LinkedIn

© 2022, 2023 Bayer

The descriptions, claims and visuals for all non-Bayer owned applications originate and are obtained from the application providers, or excerpted from publicly available information. Bayer is providing this content for your information, but does not own and control such content.

BAYER, the Bayer Cross and Calantic are trademarks owned by Bayer and/or registered in the U.S. Other trademarks and company names mentioned herein are properties of their respective owners.

This is intended to provide information for healthcare professionals and other relevant decision makers in the US. Not all offerings are available in all markets. For availability specific to your country please contact your local Bayer representative. These materials are exclusively for professional use.

 

Consult the operating instructions of a product for its intended use, characteristics and performance, contraindications, name of the manufacturer or its authorized representative and other essential information.

 

You are encouraged to report adverse events; reporting information can be found on https://www.bayer.com/en/pharma/report-side-effect

Any individuals depicted in this website are actors and not actual health care providers or patients. All patient data is fictitious. Images are an artistic representation for illustrative purposes only.

 

Last Updated: August 2023

Bayer Logo